138 related articles for article (PubMed ID: 8933671)
1. Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure.
Yumita S; Suzuki M; Akiba T; Akizawa T; Seino Y; Kurokawa K
Tohoku J Exp Med; 1996 Sep; 180(1):45-56. PubMed ID: 8933671
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
Kates DM; Sherrard DJ; Andress DL
Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
[TBL] [Abstract][Full Text] [Related]
4. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
Ishimura E; Nishizawa Y; Inaba M; Matsumoto N; Emoto M; Kawagishi T; Shoji S; Okuno S; Kim M; Miki T; Morii H
Kidney Int; 1999 Mar; 55(3):1019-27. PubMed ID: 10027939
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
Pettifor JM
Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
[TBL] [Abstract][Full Text] [Related]
7. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
Rudnicki M; McNair P; Transbøl I; Nielsen B
Nephron; 1991; 58(2):144-9. PubMed ID: 1865969
[TBL] [Abstract][Full Text] [Related]
8. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
[TBL] [Abstract][Full Text] [Related]
9. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
Takamoto S; Onishi T; Morimoto S; Imanaka S; Tsuchiya H; Seino Y; Yokokawa T; Iida N; Kumahara Y
Nephron; 1985; 40(3):286-91. PubMed ID: 3839293
[TBL] [Abstract][Full Text] [Related]
10. Gestational hypercalcemia: Prevalence and biochemical profile.
Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
[TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
12. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
Koskimies O; Ala-Houhala M
Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
14. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
Gannagé-Yared MH; Farès C; Ibrahim T; Rahal ZA; Elias M; Chelala D
Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
[TBL] [Abstract][Full Text] [Related]
15. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation.
Saha HH; Salmela KT; Ahonen PJ; Pietilä KO; Mörsky PJ; Mustonen JT; Lalla ML; Pasternack AI
Scand J Urol Nephrol; 1994 Mar; 28(1):21-7. PubMed ID: 8009188
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
Kruse K
J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
[TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
18. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
19. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
20. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]